Navigation Links
Study to examine direct-to-consumer drug ads on TV
Date:9/14/2011

Do pharmaceutical ads educate patients and improve health -- or merely spur drug sales?

Researchers at the University of Illinois at Chicago's Institute for Health Research and Policy will conduct the first comprehensive study of televised drug commercials using Nielsen Media Research and health care utilization data.

The research is funded by a $3 million, four-year grant from the National Heart, Lung, and Blood Institute.

The U.S. is the only country that allows televised ads for prescription drugs. Direct-to-consumer drug commercials are the fourth most common category of television advertising.

"The increase in the amount of advertising has coincided with huge increases in health care costs," said Sherry Emery, principal investigator of the project at UIC, who notes that advertising has not likely caused the entire rise in health care costs.

"On the one hand, the pharmaceutical industry claims that these advertisements provide a public service by educating consumers and giving people information to take to their doctors that might improve their health and ultimately result in lower health care costs," Emery said. "But there are a lot of economists who would suggest that you don't advertise a product unless you expect to make money from it -- and these ads might be driving excess demand."

Previous research has not demonstrated either effect conclusively, said Emery, a senior research scientist at the UIC institute, perhaps because such studies have focused on single categories of drugs. Several studies have examined the effect of direct-to-consumer advertising on consumers' behavior and health outcomes, but most have used aggregate spending rather than more refined measures of ad exposure.

"It seems reasonable that an advertisement for a cholesterol medication that treats a non-symptomatic condition might be different than an advertisement for an asthma medication, where if you don't adhere to the medication, you may end up in the hospital with a flare-up of your asthma," she said.

Emery and colleagues will use the Nielsen data to examine direct-to-consumer advertising on health care utilization and pharmaceutical sales of eight therapeutic classes of drugs promoted in the top 75 U.S. media markets from 2005-2009. The drugs include those for allergies, asthma, arthritis, depression, erectile dysfunction, hyperlipidemia, sleep disorder, and smoking cessation. Data from millions of patients will be examined for doctor visits, hospitalizations, new prescriptions, and prescription refills. The study will take into account different patient characteristics and regional differences in access to physicians.

The researchers will also evaluate the content of the ads to see how they vary among drug classes -- and whether these differences affect their impact.

There are three types of pharmaceutical ads, which are subject to different levels of regulation by the FDA: product claim ads, which include the drug name, an FDA-approved use, and the most significant risks; reminder ads, which give the name of the drug but not its uses, which do not have to contain risk information; and help-seeking ads, which describe a disease or condition but do not recommend a specific treatment.

"It's conceivable that the different types of advertising are used differently by drug class and that they might affect the way people respond to the advertisement in terms of their health-seeking behavior and their demand for the medication," said Emery.


'/>"/>

Contact: Sherri McGinnis McGinnis
smcginn@uic.edu
312-996-8277
University of Illinois at Chicago
Source:Eurekalert

Related medicine news :

1. Drinking Patterns Affect Heart Health, Mouse Study Finds
2. Quitting Smoking May Improve Personality, Study Suggests
3. More Mammograms Equal More Mastectomies: Study
4. Study finds over 70 percent of suicidal teens dont get the mental health services they need
5. Diabetes public health: UCSF study highlights need for better guidelines
6. Institute for Aging Research study finds Bostons elderly homeless sicker than others
7. Statins Dont Raise Risk of Brain Bleeds After Stroke: Study
8. Strong leadership necessary to provide more sophisticated care for aging population, study finds
9. New Drug Boosts Good Cholesterol in Study Patients
10. IUDs May Lower Womens Risk for Cervical Cancer: Study
11. Eye Antibiotics Can Cause Drug-Resistant Bacteria: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... Ellevate Network, the leading network for professional women, brought together some ... at their inaugural Summit in New York City in June. The event was livestreamed ... over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... 2017 , ... Dr. Parsa Mohebi, the Los Angeles based ... the newly revamped Cosmetic Town journal section, featuring articles written by ... as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I enjoy ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the ... analysis system called the HORIZON at MIBio 2017 in ... subvisible and visible particulate matter in biopharmaceutical samples with unprecedented speed ... of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
Breaking Medicine Technology: